Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.

Main|Search|PHGKB



Last Posted: Jul 13, 2018

---

• Underdiagnosis of Hereditary Breast and Ovarian Cancer in Medicare Patients: Genetic Testing Criteria Miss the Mark.  
  Yang Shan et al. Annals of surgical oncology 2018 Jul
• "I Am Uncertain About What My Uncertainty Even Is": Men's Uncertainty and Information Management of Their BRCA-Related Cancer Risks.  
  Rauscher Emily A et al. Journal of genetic counseling 2018 Jul
• Comprehensive Proteomic Profiling-derived Immunohistochemistry-based Prediction Models for BRCA1 and BRCA2 Germline Mutation-related Breast Carcinomas.  
  Vos Shoko et al. The American journal of surgical pathology 2018 Jul
• Genetic screening can inform women of their breast and ovarian cancer risks  
  L Abaid, LA Times, July 5, 2018
• Surgeons Influence Receipt of Genetic Testing After Breast Cancer Diagnosis  
  N Fawcett, University of Michigan Health Lab Blog, July 3, 2018
• Bone loss in women with BRCA1 and BRCA2 mutations.  
  Powell C Bethan et al. Gynecologic oncology 2018 148(3) 535-539
• Clinicopathologic Characterization of Breast Carcinomas in Patients with Non-BRCA Germline Mutations: Results from a Single Institution's High Risk Population.  
  Meiss Alice E et al. Human pathology 2018 Jun
• Consideration of Population-Based BRCA Testing as a Strategy to Reduce Disparities in Genetic Counseling Referrals: The Importance of Stating (and Proving) the Obvious.  
  Newman Lisa A et al. JAMA surgery 2018 Jul
• Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.  
  Gill Jennifer et al. JAMA 2018 Jun 319(23) 2377-2378
• Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer  
  SJ Katz et al. JAMA Surgery, July 3, 2018

more